{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:19:44Z","timestamp":1793895584682,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neulet.2023.137597","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:14:15Z","timestamp":1702725255000},"page":"137597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory"],"prefix":"10.1016","volume":"820","author":[{"given":"Hector","family":"Vargas-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Minauro-Sanmiguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Ting-A-Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn Elizabeth","family":"Grieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"M\u00e9ndez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Prosp\u00e9ro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"van der Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137597_b0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1037\/h0036128","article-title":"An opponent-process theory of motivation. I. Temporal dynamics of affect","volume":"81","author":"Solomon","year":"1974","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neulet.2023.137597_b0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0091-3057(96)00438-8","article-title":"Opponent process model and psychostimulant addiction","volume":"57","author":"Koob","year":"1997","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1","key":"10.1016\/j.neulet.2023.137597_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","article-title":"Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement","volume":"111","author":"Baker","year":"2004","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neulet.2023.137597_b0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/npp.2009.198","article-title":"Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine","volume":"35","author":"Grieder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2023.137597_b0025","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1460-9568.2009.06749.x","article-title":"Different neural systems mediate morphine reward and its spontaneous withdrawal aversion","volume":"29","author":"Vargas-Perez","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137597_b0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neulet.2023.137597_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as Medicines: An Emerging New Paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.neulet.2023.137597_b0040","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review","volume":"47","author":"DiVito","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.neulet.2023.137597_b0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neubiorev.2016.10.026","article-title":"Classical hallucinogens and neuroimaging: A systematic review of human studies: hallucinogens and neuroimaging","volume":"71","author":"dos Santos","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neulet.2023.137597_b0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S2215-0366(15)00576-3","article-title":"Brewerton TD. Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA","volume":"3","author":"Mithoefer","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.neulet.2023.137597_b0055","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neulet.2023.137597_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"9","key":"10.1016\/j.neulet.2023.137597_b0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"dos Santos","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"258","key":"10.1016\/j.neulet.2023.137597_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","volume":"1","author":"Muttoni","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2023.137597_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/18744737112059990023","article-title":"The potential of psychedelics as a preventative and auxiliary therapy for drug abuse","volume":"6","author":"Vargas-Perez","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neulet.2023.137597_b0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","article-title":"Adverse reactions to psychedelic drugs. A review of the literature","volume":"172","author":"Strassman","year":"1984","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neulet.2023.137597_b0085","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ejn.13572","article-title":"van der Kooy, D (2017) A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents","volume":"45","author":"Vargas-Perez","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2023.137597_b0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Therap."},{"issue":"3","key":"10.1016\/j.neulet.2023.137597_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/pha0000253","article-title":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats","volume":"27","author":"Sakloth","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2023.137597_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.2005.10399794","article-title":"Report on psychoactive drug use among adolescents using ayahuasca within a religious context","volume":"37","author":"Doering-Silveira","year":"2005","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neulet.2023.137597_b0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2023.137597_b0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-1999-3490","article-title":"Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetyl prodrug of psilocin","volume":"6","author":"Nichols","year":"1999","journal-title":"Synthesis"},{"key":"10.1016\/j.neulet.2023.137597_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-2952(62)90050-3","article-title":"The fate of psilocin in the rat","volume":"11","author":"Kalberer","year":"1962","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2023.137597_b0120","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"issue":"8","key":"10.1016\/j.neulet.2023.137597_b0125","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0043-1354(95)00323-1","article-title":"Extraction of extracellular polymers from activated sludge using a cation exchange resin","volume":"30","author":"Frolund","year":"1996","journal-title":"Water Res."},{"key":"10.1016\/j.neulet.2023.137597_b0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin Phenol Reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2023.137597_b0140","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.3776-13.2014","article-title":"BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions","volume":"34","author":"Vargas-Perez","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137597_b0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nn1182","article-title":"Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area","volume":"7","author":"Laviolette","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2023.137597_b0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/0735-7044.109.1.91","article-title":"Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal","volume":"109","author":"Bechara","year":"1995","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neulet.2023.137597_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Os\u00f3rio Fde","year":"2019","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"7","key":"10.1016\/j.neulet.2023.137597_b0165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"11(4)","key":"10.1016\/j.neulet.2023.137597_b0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/jcm11041147","article-title":"Ayahuasca as a decoction applied to human: analytical methods, pharmacology and potential toxic effects","volume":"21","author":"Ni\u017enansk\u00fd","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neulet.2023.137597_b0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada","volume":"6","author":"Thomas","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neulet.2023.137597_b0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02791072.2013.873157","article-title":"Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence\u2013qualitative results","volume":"46","author":"Loizaga-Velder","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neulet.2023.137597_b0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnbeh.2014.00180","article-title":"The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat","volume":"8","author":"Rambousek","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"25","key":"10.1016\/j.neulet.2023.137597_b0190","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jchromb.2011.07.003","article-title":"Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis","volume":"879","author":"Chen","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neulet.2023.137597_b0195","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.1168501","article-title":"Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats","volume":"324","author":"Vargas-Perez","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neulet.2023.137597_b0200","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1111\/j.1460-9568.2007.05599.x","article-title":"A test of the opponent-process theory of motivation using lesions that selectively block morphine reward","volume":"25","author":"Vargas-Perez","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137597_b0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2023.137597_b0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2023.137597_b0215","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1523\/JNEUROSCI.4036-14.2015","article-title":"Microglia disrupt mesolimbic reward circuitry in chronic pain","volume":"35","author":"Taylor","year":"2015","journal-title":"J. Neurosci."},{"issue":"109(16)","key":"10.1016\/j.neulet.2023.137597_b0220","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"18","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2023.137597_b0225","first-page":"1","article-title":"Neural plasticity in the ventral tegmental area, aversive motivation during drug withdrawal and hallucinogenic therapy","volume":"3","author":"Vargas-Perez","year":"2022","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.neulet.2023.137597_b0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2023.137597_b0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023005566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023005566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:50:57Z","timestamp":1759625457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023005566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S0304394023005566"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137597","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137597"}}